Trade

with

Karyopharm Therapeutics Inc.
(NASDAQ: KPTI)
AdChoices
35.49
+1.85
+5.50%
After Hours :
-
-
-

Open

34.61

Previous Close

33.64

Volume (Avg)

104.12k (222.26k)

Day's Range

34.00-36.50

52Wk Range

15.50-47.98

Market Cap.

1.10B

Dividend Rate ( Yield )

-

Beta

-

Shares Outstanding

32.67M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 387.00k

    • Net Income

    • -33.95M

    • Market Cap.

    • 1.10B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -24,108.41

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -

    • Forward P/E

    • -14.08

    • Price/Sales

    • 3,333.33

    • Price/Book Value

    • 8.33

    • Price/Cash flow

    • -16.31

      • EBITDA

      • -33.80M

      • Return on Capital %

      • -51.55

      • Return on Equity %

      • -53.85

      • Return on Assets %

      • -51.55

      • Book Value/Share

      • 4.03

      • Shares Outstanding

      • 32.67M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 50.00

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -2.59

        • Cashflow Estimate

        • -2.34

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -84.20

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 100.00

            • 64.72

            • Pre-Tax Margin

            • -24,108.41

            • 13.77

            • Net Profit Margin

            • -24,108.41

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 23.96

              • 1.52

              • Quick Ratio

              • 23.43

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 1.05

              • 1.91

              • Book Value/Share

              • 4.03

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -13.09

                • 63.69

                • P/E Ratio 5-Year High

                • -18.35

                • 237.47

                • P/E Ratio 5-Year Low

                • -5.93

                • 19.71

                • Price/Sales Ratio

                • 3,333.33

                • 3.64

                • Price/Book Value

                • 8.50

                • 3.39

                • Price/Cash Flow Ratio

                • -16.31

                • 21.79

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -53.85

                    (-)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • -51.55

                    (-)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • -53.85

                    (-)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • -

                  • 27.79k

                  • Inventory Turnover

                  • -

                  • 1.80

                  • Asset Turnover

                  • 0.00

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -33.95M
                  Operating Margin
                  -8,772.61
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -16.31
                  Ownership

                  Institutional Ownership

                  94.27%

                  Top 10 Institutions

                  89.02%

                  Mutual Fund Ownership

                  35.21%

                  Float

                  41.59%

                  5% / Insider Ownership

                  4.48%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    2,838,328

                  • 5.73

                  • 8.69

                  • Franklin Biotechnology Discovery

                  •  

                    969,868

                  • 92.64

                  • 3.26

                  • Franklin Biotechnology Discovery Fund

                  •  

                    647,400

                  • 20.38

                  • 1.98

                  • Franklin Small Cap Growth Fund

                  •  

                    507,686

                  • 17.82

                  • 1.55

                  • Fidelity Advisor® Biotechnology Fund

                  •  

                    503,174

                  • 6.16

                  • 1.54

                  • Fidelity® Contrafund® Fund

                  •  

                    501,200

                  • 0.00

                  • 1.53

                  • SPDR® S&P Biotech ETF

                  •  

                    436,518

                  • 0.00

                  • 1.31

                  • BlackRock Health Sciences Opps Port

                  •  

                    414,139

                  • 0.00

                  • 1.27

                  • Franklin Small-Mid Cap Growth Fund

                  •  

                    341,700

                  • 0.00

                  • 1.05

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Franklin Advisers, Inc.

                  •  

                    4,228,080

                  • +111.36%

                  • 14.23

                  • Fidelity Management and Research Company

                  •  

                    3,414,131

                  • +45.53%

                  • 11.49

                  • Foresite Capital Management I, LLC

                  •  

                    1,377,410

                  • -13.14%

                  • 4.63

                  • BlackRock Advisors LLC

                  •  

                    736,935

                  • +15.57%

                  • 2.48

                  • Partner Fund Management LP

                  •  

                    662,842

                  • +114.10%

                  • 2.23

                  • AllianceBernstein LP

                  •  

                    412,479

                  • -7.60%

                  • 1.39

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Distressed

                  Style

                  -

                  Karyopharm Therapeutics Inc., is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

                  Key People

                  Dr. Michael G. Kauffman,M.D.,PhD

                  CEO/Co-Founder/Director

                  Dr. Sharon Shacham, M.B.A.,PhD

                  Chief Scientific Officer/Founder/President

                  Justin Renz

                  Executive VP/CFO

                  Christopher Brett Primiano

                  General Counsel/Secretary/Vice President, Divisional

                  Barry E. Greene

                  Director

                  • Karyopharm Therapeutics Inc.

                  • 2 Mercer Road

                  • Natick, MA 01760

                  • USA.Map

                  • Phone: +1 508 975-4820

                  • Fax: -

                  • karyopharm.com

                  Incorporated

                  2008

                  Employees

                  31

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: